Epoch Biodesign
Epoch Biodesign is a startup headquartered in London, United Kingdom, founded in 2019. It has won about £1.40m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Epoch Biodesign has won about £1.40m in competitive Innovate UK grants since 2023.
- Fibre-to-fibre Nylon recycling for circular fashion using DAM-2-MULTI enyzme technology (£700k, 2025)
- DAM-2: A novel enzyme for Nylon-6,6 recycling (£350k, 2023)
- NJA-1: A novel synthetic enzyme designed to transform polyolefin recycling (£350k, 2023)
R&D ecosystem
Epoch Biodesign sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Epoch Biodesign do?
Epoch Biodesign works in biotechnology. Its Innovate UK projects include: Fibre-to-fibre Nylon recycling for circular fashion using DAM-2-MULTI enyzme technology.
Where is Epoch Biodesign based?
Epoch Biodesign is headquartered in London, United Kingdom.
When was Epoch Biodesign founded?
Epoch Biodesign was founded in 2019.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.